About us
Organization
Life Science Innovation Network Japan(LINK-J)
The Management Advisory Committee comprises experts from industry and academia who diligently employ their expertise and broad insight to support LINK-J's activities.The Committee also provides strategic advice to the Board of Directors.Directors and Auditors
Chairman of the Board | Hideyuki Okano, M.D., Ph.D. | Director and Distinguished Professor of Keio University Regenerative Medicine Research Center |
Vice Chairman of the Board | Yoshiki Sawa, M.D., Ph.D. | Specially Appointed Professor Division of Health science Osaka University Graduate School of Medicine, Director,Osaka Police Hospital |
Vice Chairman of the Board | Takashi Ueda | President and Chief Executive Officer, Mitsui Fudosan Co., Ltd. |
Chief Executive Officer | Akihiko Soyama | LINK-J |
Co-Chief Executive Officer | Hiroshi Saigusa | LINK-J |
Auditor | Yutaro Kikuchi | Attorney at law, Kikuchi Sogo Law Office |
Auditor | Shigeru Sugimoto | CEO, Sakura & Co. |
Management Advisory Committee Members
The Management Advisory Committee comprises experts from industry and academia who diligently employ their expertise and broad insight to support LINK-J's activities. The Committee also provides strategic advice to the Board of Directors.
Special Advisor | Yoichiro Matsumoto, Dr. Eng. | Professor Emeritus, The University of Tokyo |
Advisor | Hiroaki Ueno | President, Japan Pharmaceutical Manufacturers Association (JPMA) President & Representative Director, Mitsubishi Tanabe Pharma Corporation |
Advisor | Shinji Ohnishi | Vice President Deputy Director General of Research and Industrial Collaboration Management office, Kyushu University |
Advisor | Yasushi Okada | President, The Federation of Pharmaceutical Manufacturers' Associations of JAPAN (FPMAJ) Representative Corporate Officer, COO and Industry Affairs,Eisai Co., Ltd. |
Advisor | Keiji Kojima | Director, Representative Executive Officer, President & CEO and Director, Hitachi, Ltd |
Advisor | Yoshitsugu Shitaka, Ph.D. | Chairman, Forum for Innovative Regenerative Medicine (FIRM) Chief Scientific Officer, Astellas Pharma Inc. |
Advisor | Takao Someya, Ph.D. | The University of Tokyo, Director General, Division of University Corporate Relations |
Advisor | Jun Takahashi M.D., Ph.D. | Professor, Director of Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan |
Advisor | Tsuyoshi Toyama | Director, Office of Cooperative Research and Development, Tohoku University |
Advisor | Masaaki Mizuno, M.D., Ph.D. | Clinical Professor, Nagoya University Hospital Department of Advanced Medicine Center for Advanced medicine and Clinical Research Director |
Advisor | Kohei Miyazono., M.D., Ph.D. | Executive Director, RIKEN |
Advisor | Koji Murota | Director-General for Office of Society-Academia Collaboration for Innovation, Kyoto University |
Advisor | Akio Yamamoto | Chairman, the Japan Federation of Medical Devices Associations Senior Adviser, FUJIFILM Medical Co.,Ltd |
Advisor | Shinji Wakao, Ph.D. | Vice President for Research, and Professor, Faculty of Science and Engineering, Waseda University |
Advisor | Masanobu Komoda | Chairman of the Board, Mitsui Fudosan Co., Ltd. |
Executive Office
President and Chief Operating Officer | Shunichi Takahashi, Ph.D. |